Akira Horikoshi
Itabashi, 1738610, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Dasatinib rapidly induces deep molecular response in chronic-phase chronic myeloid leukemia patients who achieved major molecular response with detectable levels of BCR-ABL1 transcripts by imatinib therapy.
Journal: International journal of clinical oncology
Published: March 09, 2017
Safety and efficacy of high-dose cyclophosphamide, etoposide and ranimustine regimen followed by autologous peripheral blood stem cell transplant for patients with diffuse large B-cell lymphoma.
Journal: Leukemia & lymphoma
Published: February 05, 2014
Enhancement of differentiation induction and upregulation of CCAAT/enhancer-binding proteins and PU.1 in NB4 cells treated with combination of ATRA and valproic acid.
Journal: International journal of oncology
Published: November 02, 2013
Aquaporin 9, a promising predictor for the cytocidal effects of arsenic trioxide in acute promyelocytic leukemia cell lines and primary blasts.
Journal: Oncology reports
Published: December 24, 2012
Efficacy of oral cytarabine ocfosfate and etoposide in the treatment of elderly patients with higher-risk myelodysplastic syndromes compared to that in elderly acute myeloid leukemia patients.
Journal: Chemotherapy
Published: October 02, 2012
Efficacy of a dose-intensified CHOP (Double-CHOP) regimen for peripheral T-cell lymphomas.
Journal: Oncology reports
Published: September 17, 2012
Successful childbearing in two women with rheumatoid arthritis and a history of miscarriage after etanercept treatment.
Journal: Rheumatology international
Published: December 23, 2011
Speciation of arsenic trioxide metabolites in peripheral blood and bone marrow from an acute promyelocytic leukemia patient.
Journal: Journal of hematology & oncology
Published: November 13, 2011
Showing 1-10 of 10
Last Updated: 09/26/2026